Symphony Limited (SYMPHONY)

Consumer Durables · Consumer Durables · NSE · Updated 15 July 2026
₹702.7 ↓ 39.96% (1Y)

🎯 Key Takeaways

  • Symphony Limited is in a strategic restructuring phase, shifting focus from loss-making international operations to core profitable segments in India, particularly its Beyond India Summer Products and air cooler business. The company is exiting Australia after significant impairments and capital reallocation, while maintaining shareholder returns through dividends despite recent profitability challenges.
  • Revenue declined 23.2% QoQ to ₹242 in Q3FY25.
  • ⚠️ Ongoing integration risks and profitability uncertainty in newly acquired U.S. and Mexico businesses.
Market Cap
₹5,385
P/E Ratio
29.6
Div Yield
0.00%
Promoter
0.0%

📖 The Story

Symphony Limited is in a strategic restructuring phase, shifting focus from loss-making international operations to core profitable segments in India, particularly its Beyond India Summer Products and air cooler business. The company is exiting Australia after significant impairments and capital reallocation, while maintaining shareholder returns through dividends despite recent profitability challenges. This transformation reflects a deliberate pivot to improve capital efficiency and long-term sustainability.

📰 What's Happening

In Q4 FY26, Symphony reported consolidated revenue of ₹338 crores, down 30.7% YoY, driven by declines in both consolidated and stand-alone operations, with PAT turning negative ₹141 crores due to ₹259 crores in Australia business impairments. Management highlighted the successful repayment of ₹165 crores in loans, acquisition of U.S. and Mexico subsidiaries for ₹52 crores, and no further capital investment in Australia. Despite the downturn, they emphasized resilience in gross margins (stable at 46.4%) and early signs of recovery in key Indian markets during April, with BISP products contributing ₹192 crores in revenue.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ4FY23Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25
Revenue308302275247332531315242
Operating Profit334052596612084-10
OPM %7.5%8.6%14.9%17.8%17.2%20.9%20.3%12.0%
Net Profit16243541488856-10
EPS₹2.29₹3.44₹5.06₹5.91₹7.02₹12.76₹8.11₹-1.37

The company's financial trajectory shows a sharp decline in revenue and profitability over the past four quarters, with Q1 FY25 revenue at ₹531 crores and PAT at ₹88 crores, contrasting sharply with Q4 FY26's ₹338 crores revenue and negative ₹141 crores PAT. This deterioration is directly linked to impairments in the Australia business and broader international segment challenges, despite stable gross margins. Management attributes the downturn to transitional phases in restructuring, with expectations of recovery through U.S. and GSK China becoming capital accretive and operational improvements in India.

🔮 Management Outlook & What's Next

Management expressed confidence in the U.S. and GSK China acquisitions becoming capital accretive and anticipated the GSK China loan repayment of ₹4 crores within the next six months. They also outlined plans for the Australia distribution model shift to reduce fixed costs and for BISP products to achieve EBITDA margins comparable to the air cooler business. No specific forward guidance on revenue or profitability was provided, but the focus remains on capital efficiency and exiting non-core markets.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Consumer Durables

Company MCap (₹ Cr) P/E ROCE ROE D/E
Titan Company Limited 3.70 L Cr 77.6 34.3% 41.0% 0.88
Asian Paints Limited 2.50 L Cr 65.0 26.0% 19.8% 0.04
LG Electronics India Limited 1.07 L Cr
Havells India Limited 75,873 54.2
Dixon Technologies (India) Limited 66,754 75.9
Berger Paints (I) Limited 62,200 54.5
Voltas Limited 40,722 56.8
Kalyan Jewellers India Limited 36,461 54.6
Blue Star Limited 34,091 61.2
Amber Enterprises India Limited 29,854 164.3 8.4% 4.1% 0.62

🔗 Peer Stock Analyses

⚠️ Risk Factors

1. Ongoing integration risks and profitability uncertainty in newly acquired U.S. and Mexico businesses. 2. Execution risks in the Australia distribution model shift, which is critical to reducing fixed costs and improving margins. 3. Dependence on the timing and success of GSK China loan repayment and capital accretion from international acquisitions. 4. Macroeconomic pressures in key markets affecting consumer demand for durable goods.

📋 Recent Filings

🧠 Analyst's Read

Symphony is undergoing a strategic transformation with significant impairments from past international investments, but is taking concrete steps to restructure and refocus on profitable Indian operations and select overseas acquisitions. The company's ability to stabilize margins, execute its Australia exit plan, and deliver capital efficiency from new ventures will be critical to reversing the current downturn. Investors should monitor upcoming management commentary, particularly from the May 18 broadcast, for updated timelines on U.S. and China recovery and capital deployment plans.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when SYMPHONY files new disclosures

Track SYMPHONY filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SYMPHONY — Free

Free account · 2 AI queries/day